Brief: Lumos Diagnostics Enters Strategic Collaboration With AcuityMD
20/11/2025 01:21
Nov 20 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX: ENTERS STRATEGIC COLLABORATION WITH ACUITYMD TO SUPPORT U.S. COMMERCIALIZATION OF FEBRIDX TEST Further company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Diagnostics Holdings
See all newsBrief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million